SCHEMBL6900940

SCHEMBL6900940

CCCCCc1ccc(C=O)cc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 3/20 0.60
CYP3A4 P08684 2/20 0.60
MAPT P10636 2/20 0.60
MEN1 O00255 1/20 0.60
TP53 P04637 1/20 0.60
ALOX5 P09917 1/20 0.60
ALOX15 P16050 1/20 0.60
TSHR P16473 1/20 0.60
HTT P42858 1/20 0.60
KMT2A Q03164 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
KDM4E B2RXH2 2/20 0.48
PTGS2 P35354 1/20 0.48
RAB9A P51151 1/20 0.48
ALDH1A1 P00352 3/20 0.45
AOX1 Q06278 1/20 0.45
APP P05067 1/20 0.43
CNR2 P34972 2/20 0.43
USP2 O75604 1/20 0.42
GLA P06280 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7249367 0.95 TYR (0.61) TYRCYP3A4MAPTMEN1TP53
SCHEMBL7251582 0.88 KDM4E (0.53) TYRCYP3A4MAPTMEN1TP53
SCHEMBL3432924 0.87 ALDH1A1 (0.49) TYRCYP3A4MAPTMEN1TP53
SCHEMBL11503809 0.85 TYR (0.50) TYRCYP3A4MAPTMEN1TP53
SCHEMBL28750170 0.83 TYR (0.42) TYRCYP3A4MAPTMEN1TP53
SCHEMBL5077090 0.83 TSHR (0.46) TYRCYP3A4MAPTMEN1TP53
SCHEMBL28228167 0.83 TSHR (0.46) TYRCYP3A4MAPTMEN1TP53
SCHEMBL3431177 0.82 KDM4E (0.59) TSHRTDP1KDM4EPTGS2RAB9A
SCHEMBL11410036 0.82 TYR (0.63) TYRCYP3A4MAPTMEN1TP53
SCHEMBL3430982 0.81 ALDH1A1 (0.50) TYRCYP3A4MAPTMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments CUTANIX CORPORATION 2003-08-21 US claimed
EP-1443915-A1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES Cutanix Corporation (US) 2004-08-11 EP disclosed
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments CUTANIX CORPORATION 2003-08-21 US disclosed
WO-2003043621-A1 PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES CUTANIX CORPORATION (US) 2003-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030157154-A1 Compositions containing hydroxy aromatic aldehydes and their use in treatments TYR, HRH1, HRH2 TYR 1/4885CYP3A4 834/4885MAPT 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.